Frossard N, Pauli G, Landry Y
Agents Actions. 1981 Dec;11(6-7):653-4. doi: 10.1007/BF01978782.
Antianaphylactic properties have been attributed to cyclic nucleotide phosphodiesterase inhibitors through increase of cyclic AMP levels, according to the concept that increases in cyclic AMP reduce release and increases in cyclic GMP enhance release. However, Coulson et al. [3] showed that the inhibition of histamine release from human lung is correlated to the inhibition of cyclic GMP hydrolysis. We studied the effect of specific inhibitors of cyclic AMP and cyclic GMP hydrolysis on the antigen-induced mediator release from rat mass cells and human basophils and on airways relaxation [4]. The results suggested that the modulation of mediator release was different from one cell type to the other, enhancement of cyclic AMP levels leading to the inhibition of release from basophils, while cyclic GMP appears to be predominantly involved in mast cells. The present paper shows that high concentrations of sodium nitrite, a stimulating agent of guanylate cyclase, inhibit histamine release from rat mast cells in the presence or absence of M&B 22948, a selective cyclic GMP phosphodiesterase inhibitor.
根据环磷酸腺苷(cAMP)水平升高会减少释放,而环磷酸鸟苷(cGMP)水平升高会增强释放这一概念,抗过敏性特性已归因于环核苷酸磷酸二酯酶抑制剂,因为它们能提高cAMP水平。然而,库尔森等人[3]表明,抑制人肺组织中组胺释放与抑制cGMP水解相关。我们研究了cAMP和cGMP水解的特异性抑制剂对抗原诱导的大鼠肥大细胞和人嗜碱性粒细胞介质释放以及气道舒张的影响[4]。结果表明,不同细胞类型中介质释放的调节方式不同,cAMP水平升高导致嗜碱性粒细胞释放受到抑制,而cGMP似乎主要参与肥大细胞的过程。本文表明,高浓度的亚硝酸钠(一种鸟苷酸环化酶刺激剂)在有或没有选择性cGMP磷酸二酯酶抑制剂M&B 22948存在的情况下,均可抑制大鼠肥大细胞释放组胺。